Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Verrica Pharmaceuticals Inc VRCA

Healthcare
Verrica Pharmaceuticals Inc. is a dermatology therapeutics company. The Company is focused on developing and commercializing treatments for skin diseases. Its product pipeline consists of three product candidates: YCANTH, VP-315 and VP-103. YCANTH is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin. We are also developing YCANTH for potential... see more

Recent & Breaking News (NDAQ:VRCA)

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm

Newsfile June 22, 2022

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Verrica Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 5, 2022 - (NASDAQ: VRCA)

PR Newswire June 22, 2022

DEADLINE ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 5, 2022 in Verrica Lawsuit - VRCA

Newsfile June 21, 2022

VRCA ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 5, 2022 in the Class Action Filed on Behalf of Verrica Pharmaceuticals, Inc. Shareholders

PR Newswire June 21, 2022

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm

Newsfile June 20, 2022

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Verrica Investors of a Lead Plaintiff Deadline of August 5, 2022

PR Newswire June 20, 2022

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm

Accesswire June 17, 2022

Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Verrica Pharmaceuticals, Inc. (VRCA) Investors and Encourages Investors to Contact the Firm Before August 5, 2022

Business Wire June 17, 2022

VRCA SHAREHOLDER ALERT: Jakubowitz Law Reminds Verrica Shareholders of a Lead Plaintiff Deadline of August 5, 2022

PR Newswire June 17, 2022

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Verrica Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VRCA

PR Newswire June 16, 2022

VRCA Investors Have Opportunity to Lead Verrica Pharmaceuticals Inc. Securities Fraud Lawsuit

PR Newswire June 16, 2022

VRCA LAWSUIT ALERT: Levi & Korsinsky Notifies Verrica Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

PR Newswire June 16, 2022

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verrica Pharmaceuticals, Inc. -VRCA

Newsfile June 15, 2022

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm

Newsfile June 15, 2022

VERRICA PHARMACEUTICALS INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of Pennsylvania against Verrica Pharmaceuticals Inc.

PR Newswire June 15, 2022

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Verrica Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 5, 2022 - (NASDAQ: VRCA)

PR Newswire June 15, 2022

ROSEN, National Trial Lawyers, Encourages Verrica Pharmaceuticals Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - VRCA

Newsfile June 14, 2022

Verrica Class Action: Levi & Korsinsky Reminds Verrica Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 5, 2022 - VRCA

Newsfile June 14, 2022

VRCA ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 5, 2022 in the Class Action Filed on Behalf of Verrica Pharmaceuticals, Inc. Shareholders

PR Newswire June 14, 2022

VRCA ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 5, 2022 in the Class Action Filed on Behalf of Verrica Pharmaceuticals, Inc. Limited Shareholders

Newsfile June 13, 2022